Видео ютуба по тегу Biliary_Tract_Cancer

AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley
AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley
Genomic spectra of biliary tract cancer
Genomic spectra of biliary tract cancer
Unveiling the Mysteries of Biliary Tract Cancer: A Deep Dive into Cholangiocarcinoma
Unveiling the Mysteries of Biliary Tract Cancer: A Deep Dive into Cholangiocarcinoma
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
Future developments in immunotherapy for treatment of biliary tract cancer
Future developments in immunotherapy for treatment of biliary tract cancer
What Is Biliary Tract Cancer? Fortis Explains
What Is Biliary Tract Cancer? Fortis Explains
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
Applied precision cancer medicine in advanced biliary tract cancer
Applied precision cancer medicine in advanced biliary tract cancer
AC22 - TOPAZ-1 Trial in Biliary Tract Cancer
AC22 - TOPAZ-1 Trial in Biliary Tract Cancer
Efficacy of nanoliposomal irinotecan in biliary tract cancer
Efficacy of nanoliposomal irinotecan in biliary tract cancer
Advances in treating biliary tract cancers with targeted therapies
Advances in treating biliary tract cancers with targeted therapies
Understanding Biliary Tract Cancers with Dr. Sanjay Govil
Understanding Biliary Tract Cancers with Dr. Sanjay Govil
Biliary Tract Cancer Treatments
Biliary Tract Cancer Treatments
Dr Harding on the Rationale for Targeting FGFR2 in Cholangiocarcinoma and Biliary Tract Cancer
Dr Harding on the Rationale for Targeting FGFR2 in Cholangiocarcinoma and Biliary Tract Cancer
Regorafenib in refractory biliary tract cancer
Regorafenib in refractory biliary tract cancer
Updates in the use of neratinib in fibrolamellar carcinoma and biliary tract cancer
Updates in the use of neratinib in fibrolamellar carcinoma and biliary tract cancer